More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes. Monitoring blood glucose levels is ...

At the 61st European Association for the Study of Diabetes in Vienna, Austria, researchers highlighted emerging evidence linking both type 1 diabetes (T1D) and type 2 diabetes (T2D) with dementia and ...

The Great Pyramid aligns almost perfectly with the Earth’s cardinal points. Coincidence, genius engineering, or knowledge we can’t explain even today? Trump announces deal to lower weight loss drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with overweight and type 1 diabetes using ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved oral semaglutide for primary and secondary prevention of CV events in high-risk adults with ...

Rybelsus (semaglutide) has now been approved it for use by adults with type 2 diabetes who have high risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack ...

The Food and Drug Administration approved Novo Nordisk’s NOVO.B1.23%increase; green up pointing triangle oral GLP-1 medication to reduce the risk of major cardiovascular events in high-risk adults ...

Pawtucket is once again seeking a developer to revitalize the area around the former Apex department store. The city's previous redevelopment effort was paused in an unsuccessful attempt to convince ...

The singer has teamed up with other prominent figures with diabetes for Beyond the Misconceptions, a new initiative from his nonprofit, Beyond Type 1 Beyond Type 1 Nick Jonas has teamed up with other ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. A little more than a century ago a diagnosis ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...